Nocturnal Enuresis Market By Drug Class (Desmopressin, Imipramine, Oxybutynin, Combined Pharmacotherapy, Antidepressants), By Age Group (Children, Adolescents, Adults, Elderly), By Mechanism of Action (Vasopressin Analogues, Anticholinergic Agents, TCA {Tricyclic Antidepressants}, α-adrenergic Agonists), By End-User (Hospitals & Clinics, Specialist Clinics, Home Care, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Jun 2025 | Report ID: MI2935 | 215 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Drug Class

  • Desmopressin
  • Imipramine
  • Oxybutynin
  • Combined Pharmacotherapy
  • Antidepressants

By Age Group

  • Children
  • Adolescents
  • Adults
  • Elderly

By Mechanism of Action

  • Vasopressin Analogues
  • Anticholinergic Agents
  • TCA (Tricyclic Antidepressants)
  • α-adrenergic Agonists

By End‑User

  • Hospitals & Clinics
  • Specialist Clinics
  • Home Care
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Ferring Pharmaceuticals
  • Pfizer Inc.
  • Novartis AG
  • Astellas Pharma
  • Allergan
  • Teva Pharmaceutical Industries Ltd.
  • Mylan
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Malem Medical Ltd.
  • Wet‑Stop
  • Chummie
  • DRI Sleeper
  • TheraPee
  • DryBuddy

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing